UNC Hospitals, Investigational Drug Service — Chapel Hill, North Carolina

UNC Hospitals, Investigational Drug Service is a clinical research site located in Chapel Hill, North Carolina, United States 27514.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

UNC Hospitals, Investigational Drug Service has participated in 1 clinical trials.

Therapeutic areas: Alopecia Areata.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UNC Hospitals, Investigational Drug Service?

UNC Hospitals, Investigational Drug Service has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UNC Hospitals, Investigational Drug Service conducted?

UNC Hospitals, Investigational Drug Service has 1 clinical trials on record. Their work covers Alopecia Areata.

Is UNC Hospitals, Investigational Drug Service accredited by Crixeo Health?

UNC Hospitals, Investigational Drug Service has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UNC Hospitals, Investigational Drug Service?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.